Acrux (ASX: ACR) is a pharmaceutical company dedicated to developing and commercialising specialty and generic topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of pharmaceutical products in the US and Europe using the Patchless PatchTM, a fast-drying and invisible topical application technology. Marketed products include Axiron®, Evamist® and Lenzetto®. More recently, in addition to specialty products, Acrux has identified and initiated development of a range of generic products. Acrux is leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring more products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.
View Top Employees from AcruxWebsite | http://www.acrux.com.au |
Ticker | ACR |
Revenue | $90 billion |
Employees | 87 (50 on RocketReach) |
Founded | 1998 |
Address | 103-113 Stanley St, Melbourne, Victoria 3003, AU |
Phone | +61 3 8379 0100 |
Fax | +61 3 8379 0101 |
Technologies |
JavaScript,
HTML,
PHP
+29 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Pharmaceutical, Healthcare, Health Care |
Web Rank | 4 Million |
Keywords | Pharmaceutical Companies Victoria |
Competitors | Agile Therapeutics, Alpex Pharma SA, Lipocine Inc., OctoPlus, TARIS Bio |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 62151 Companies, NAICS Code 6215 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular Acrux employee's phone or email?
The Acrux annual revenue was $90 billion in 2024.
50 people are employed at Acrux.
Acrux is based in Melbourne, Victoria.
The NAICS codes for Acrux are [325, 32541, 32, 3254, 62151, 6215, 621, 62].
The SIC codes for Acrux are [283, 28].